Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

Abatacept - Long-Term Real-Life Experience in Psoriatic Arthritis (PsA) in Germany: an Observational Study (ALTEA)

The purpose of this study is a long-term, observational study of Abatacept in patients with Psoriatic Arthritis, a chronic inflammatory disorder.

Inclusion Criteria:

• Participants 18 years or older
• Participants who signed an informed consent
• Participants diagnosed with PsA as per the criteria of the Classification of Psoriatic Arthritis (CASPAR) Study Group18
• Participants naïve of abatacept and who at their physician's discretion initiate abatacept
• Participants meeting criteria for abatacept treatment for PsA as specified in the German label

Exclusion Criteria:

• Participants who are currently included in any interventional clinical trial in PsA/Rheumatoid Arthritis (RA)